BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/06/2026

FDA Clears Prednisolone Tablet for Sale

The US Food and Drug Administration (FDA) has made a determination that prednisolone tablet, 5 milligrams, was not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for the product.

Source: Federal Register — Health and Human ServicesOpen original release →